NG Test® SARS-CoV-2 Ag

Caratteristiche

NG TEST® SARS-CoV-2 Ag - Rapid IVD test for qualitative SARS-CoV-2 antigen detection


NG Test® SARS-CoV-2 Ag for the qualitative detection of SARS-CoV-2 antigen in nasopharyngeal and oropharyngeal samples from NG Biotech is a modern and easy-to-use rapid in vitro diagnostic test for healthcare professionals.

  • Fast: Get results in 15 minutes. Whether you test directly on sampling site or use samples in virus transport medium
  • Highly specific: Ideal for first line implementation (screening process, rapid triage of patients, ambulatory diagnostic assistance…)
  • Made in Europe: Developed and manufactured under European regulations you can be certain that the test fits your regulatory need

Detects recent variants of mutations

NG Test® SARS-CoV-2 Ag detects a nucleocapsid protein of SARS-CoV-2. The test is regularly validated for detection of new strains and mutations such as the VOC202012/1 variant (also known as B.1.1.7 or “UK strain”). For most recent information please refer to the instructions for use.

Clear transparency of clinical performance

NG Test® SARS-CoV-2 Ag was assessed in clinical studies on nasopharyngeal samples from more than 200 patients, including 100 positive samples, confirmed by RT PCR. The overall specificity was evaluated at 100% with IC95% [96-100%]. Detailed results are presented in the following tables:

 

Part No. NGB-COV-S23-028 | NG Test® SARS-CoV-2 Ag
20 tests per kit  

 

Please contact your local representative for availability in your country.
Not for sale in the USA.
Manufactured by NG Biotech Laboratories, 35480 Guipry/France. (www.ngbiotech.com)